Screening for undiagnosed pancreatic exocrine insufficiency (PEI) in a cohort of diabetic patients using faecal elastase testing and PEI scoring system.

Autor: Parihar V; Department of Gastroenterology, Tallaght University Hospital, TallaghtDublin 24, Ireland. Vikpar37@yahoo.com.; Department of Gastroenterology, Letterkenny University Hospital, Letterkenny, Ireland. Vikpar37@yahoo.com., Ballester R; Department of Gastroenterology, Tallaght University Hospital, TallaghtDublin 24, Ireland., Ridgway PF; Department of Surgery, Tallaght University Hospital and Trinity College, Dublin, Ireland., Conlon KC; Department of Surgery, Tallaght University Hospital and Trinity College, Dublin, Ireland., Gibney J; Department of Endocrinology, Tallaght University Hospital, TallaghtDublin 24, Ireland., Ryan BM; Department of Gastroenterology, Tallaght University Hospital, TallaghtDublin 24, Ireland.; Department of Clinical Medicine, Trinity College Dublin, Dublin 2, Ireland.
Jazyk: angličtina
Zdroj: Acta diabetologica [Acta Diabetol] 2024 Oct; Vol. 61 (10), pp. 1301-1307. Date of Electronic Publication: 2024 May 26.
DOI: 10.1007/s00592-024-02307-z
Abstrakt: Introduction: Type 1 and type 2 diabetes mellitus (DM) are often accompanied by mild forms of pancreatic exocrine insufficiency (PEI). The prevalence rates of PEI in diabetic patients are unclear and variable depending on the testing modality and the studies published. The clinical consequences of PEI in diabetics are also not well defined.
Aim: We aimed to determine the prevalence of PEI in a diabetic cohort using the faecal elastase-1 (FE-1) assay as a screening test and to validate a patient-reported symptom-based scoring system, the (PEI-S) for diagnosing PEI within this patient population.
Methods: Two hundred and three diabetic patients attending diabetic and gastroenterology outpatients of a university hospital without previously known PEI were recruited for the study. Demographic parameters, PEI score (PEI-S), and glycated hemoglobin (HBA1c) were documented in standardized data sheets, and a stool sample was obtained. A FE-1 value < 200 μg/g and or a PEIS of > 0.6 was used as the screening cut-off for PEI.
Results: One hundred sixty-six patients returned faecal samples. The prevalence of PEI, as measured by low FE-1, was 12%. Smoking was associated with an increased risk of developing PEI in this diabetic population. No other independent risk factors were identified. The PEI-S system did not differentiate between people with diabetes having a normal and low FE1.
Conclusion: 12% of this mixed, real-life cohort of type 1 and 2 DM patients had undiagnosed PEI, as defined by an FE-1 score of less than 200 μg/g. While this may appear low, given the rising prevalence of type 2 DM worldwide, there is likely an unrecognized burden of PEI, which has long-term health consequences for those affected. The PEI-S, a symptom-scoring system for patients with PEI, did not perform well in this patient group.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz: